Clinical efficacy of ursodeoxycholic acid in the comprehensive treatment of patients with obesity and gastroesophageal reflux disease
Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 4
Abstract
Background. Disorders in the body of patients with obesity have a systemic metabolic nature, including a negative impact on the state of the gastrointestinal tract. There was found a correlation between obesity and digestive diseases such as hepatic and pancreatic steatosis, gallstone disease, as well as gastroesophageal reflux disease (GERD). The administration of ursodeoxycholic acid (UDCA) as a part of comprehensive therapy of patients with obesity and GERD is pathogenetically justified, given its ability to influence metabolic processes in the body, as well as its protection of the mucous membrane of the upper gastrointestinal tract when exposed to aggressive refluxate. Objective: to study the clinical efficacy of the UDCA preparation (Ursofalk) in the comprehensive treatment of patients with obesity and GERD. Materials and methods. Ninety four patients with obesity of different classes and GERD were examined. They were divided into two clinical groups: group I (n = 44) received a standard treatment of GERD using a proton pump inhibitor against the background of lifestyle changes, compliance with dietary recommendations; group II (n = 50) in addition to the above-mentioned treatment received UDCA preparation Ursofalk (Dr. Falk Pharma GmbH, Germany) for 3 months. Results. GERD in patients with obesity is manifested by extraesophageal symptoms with an incidence of up to 40.9 % of cases. The prescription of proton pump inhibitor in combination with UDCA in obese patients leads to a significant reduction in heartburn, dysphagia, and extraesophageal manifestations of reflux disease by the end of weeks 2–4 of treatment. Comprehensive therapy using UDCA in the examined patients also contributed to a decrease in body weight (up to 5 kg per one month of treatment), mainly in obesity class І and ІІ. Conclusions. The use of Ursofalk in the comprehensive treatment of patients with GERD and obesity is a pathogenetically grounded mean for reducing and normalizing clinical manifestations of the disease, especially their extraesophageal forms. Comprehensive therapy of patients with GERD and obesity on the background of lifestyle modification and dietary recommendations should include UDCA preparation for faster, more effective and safe normalization of body weight with treatment duration of at least 3 months.
Authors and Affiliations
Ye. S. Sirchak
Keywords
Related Articles
- EP ID EP440800
- DOI 10.22141/2308-2097.52.4.2018.154140
- Views 87
- Downloads 0
Analysis of the Efficacy of Therapeutic Complex in Patients of Gastroenterological Profile with Candidiasis of the Mucous Membrane of the Upper Digestive Tract
The problem of the treatment for candidiasis of mucosa of the upper digestive tract remains relevant because of the need of both a causal treatment, and taking into account the variability of the immune response in the i...
Serum Gastrin Levels in Patients with Reflux Gastritis
The article presents the results of investigation of basal gastrin serum level and its relationships at chronic reflux gastritis. It has been established that gastrin level was increased in 100 % of patients. It was dire...
Hydrogen Breath Test in the Diagnosis of Digestive Tract Pathology
The article presents the information about the mo-dern method for evaluating the state of small intestine — hydrogen breath test. Two main indications for its use — bacterial overgrowth syndrome in the small intestine an...
Retrospective Analysis of the Effectiveness of Treating Patients with Duodenal Peptic Ulcer
The article presents a retrospective analysis of the effectiveness of treating patients with duodenal peptic ulcer (DPU) during 10 years, after the implementation of Maastricht consensus statements in clinical practice....
Features of the Diagnosis and Treatment of Acid-Related Disease in Patients with Diabetes Mellitus
The article considers the problem of the combined course of acid-related disorder of the gastrointestinal tract and diabetes mellitus (DM). The attention is paid to the fact that in most cases the treatment of gastroesop...